When medicine is written in code, how do you market the cure?
A quiet revolution is reshaping healthcare. From video games prescribed for ADHD to AI-powered platforms preventing diabetes, digital therapeutics (DTx) are no longer experiments-they are becoming medicine itself. And with this shift comes an urgent question for pharma: how do we market therapies made not of molecules, but of algorithms?
In Code to Cure: Digital Therapeutics and the Future of Pharma, Subba Rao Chaganti-a renowned author and thought leader in pharmaceutical marketing-offers the first comprehensive guide to understanding and leveraging digital therapeutics in the pharma landscape.
Blending rigorous research with real-world case studies, the book takes you inside the fast-evolving world of Dtx:
• What digital therapeutics are - and how they differ from wellness apps.
• Why regulators like the FDA, EMA, and Germany's DiGA are setting new global benchmarks.
• How pharmaceutical companies can align digital therapeutics (DTx) with brand strategy, payer demands, and patient needs.
• Case studies of pioneers like Pear Therapeutics, Akili Interactive, Propeller Health, Omada, and Kaia Health.
• The role of AI, wearables, and telemedicine in scaling digital care.
• Strategic frameworks for commercialization, adoption, and measuring success.
Whether you are a brand manager, marketer, student, or healthcare innovator, this book will help you navigate the opportunities and challenges of a world where medicine is not just prescribed, but downloaded.
Engaging, insightful, and practical, Code to Cure is not just about the future of pharma marketing; it is about the future of healthcare itself.
Contents:
1. Introduction to Digital Therapeutics
2. The Role of Digital Therapeutics in Healthcare Management
3. The Regulatory Landscape for Digital Therapeutics
4. Developing Digital Therapeutics: A Step-by-Step Guide
5. The Role of Pharma in Digital Therapeutics
6. The Impact of AI and Emerging Technologies on Digital Therapeutics
7. Measuring the Success of Digital Therapeutics
8. Overcoming Barriers to Adoption
9. The Future of Digital Therapeutics
10. Conclusion
